Categories

Categories

Additional Information

Additional Information

Account Navigation

Account Navigation

Currency - All prices are in AUD

Currency - All prices are in AUD
 Loading... Please wait...
Rapid Rescue

Categories

Categories

TMI

Aerobika OPEP device - TMI

$142.85 (inc GST) $142.85 (exc GST)

TMI

Aerobika OPEP device - TMI

$142.85 (inc GST) $142.85 (exc GST)
SKU:
ALQ-5485s
Weight:
0.50 KGS
Shipping:
$14.00 (Fixed shipping cost)
Quantity:

Out of Stock

Share

Product Description

Please seek medical advice to assure yourself that the Aerobika OPEP device is definitely right for you.


Aerobika*
 Oscillating Positive Expiratory Pressure Therapy System    (This Item is GST FREE)

Have you experienced a COPD exacerbation (flare-up)? Acute flare-ups are the most common reason for medical visits, hospital admissions, and deaths in patients with COPD.(1) After a COPD flare-up your lungs may be weakened putting you at risk of another. In fact, 1 in 5 patients hospitalized for a COPD flare-up require re-hospitalization within 30 days. (2)

It's time to break the COPD flare-up cycle. The drug-free Aerobika* device can help.

Using the Aerobika* device in addition to usual COPD treatment after a flare-up has been shown to reduce hospital re-admittance by 28% in the first 30 days after flare-up.(3) It is drug-free and easy-to-use with no side-effects or drug interactions.

 

In a patient satisfaction survey, 97% of respondents said they would continue to use the Aerobika* device.†4

 

 

 

 

References: 

†Patient satisfaction survey given to 504 patients after ≥3 weeks of twice-daily use of the Aerobika* device.
1 O’Donnell DE, et al. Canadian Thoracic Society recommendations for management of chronic obstructive pulmonary disease – 2007 update. Can Respir J. 2007;14(Suppl B):5B-32B.
2 Shah T, et al. COPD Readmissions: Addressing COPD in the Era of Value-Based Healthcare. Chest. 2016 May 7. doi: 10.1016/j.chest.2016.05.002. [Epub ahead of print]
3 Burudpakdee C, et al. A Real World Study of Aerobika* OPEP in Chronic Obstructive Pulmonary Disease Patients, Investigating Hospital Related Exacerbations. Manuscript.
4 Harkness H, et al. Survey of Patients Using an Oscillating Positive Expiratory Pressure Device Indicates Improvement in Well-Being and Compliance to Therapy. Presented at: Canadian Respiratory Conference. April 23–25, 2015. Ottawa, Ontario.
5 S Svenningsen et al. Presented at ERS 2014.
6 World Health Organization, Fact sheet N°310 Updated May 2014

Product Reviews

Find Similar Products by Category

Customers also viewed

Related Products

%GLOBAL_FooterScripts%%